atyr
pharma
webcast
conference
call
reporting
third
quarter
financial
results
management
host
conference
call
webcast
november
pm
est
pm
pst
san
diego
globe
newswire
atyr
pharma
nasdaq
life
biotherapeutics
company
engaged
discovery
development
innovative
medicines
based
novel
biological
pathways
today
announced
report
third
quarter
financial
results
provide
corporate
update
market
close
thursday
november
conference
call
webcast
details
thursday
november
est
pst
domestic
international
conference
id
webcast
http
atyr
atyr
biotherapeutics
company
engaged
discovery
development
innovative
medicines
based
novel
biological
pathways
atyr
research
development
efforts
concentrated
newly
discovered
area
biology
extracellular
functionality
signaling
pathways
trna
synthetases
atyr
built
global
intellectual
property
estate
directed
potential
pipeline
protein
compositions
derived
trna
synthetase
genes
extracellular
targets
atyr
primary
focus
product
candidate
binds
receptor
designed
immune
engagement
inflammatory
lung
diseases
information
please
visit
http
contact
ashlee
dunston
director
investor
relations
corporate
communications
atyr
pharma
adunston
